News

MedPage Today on MSN19hOpinion
How Fast Is Too Fast for FDA Drug Review?
In announcing his new Commissioner's National Priority Voucher (CNPV) program, FDA Commissioner Marty Makary, MD, MPH, ...
All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...
FDA Commissioner Marty Makary reportedly initiated a brief request last week to decline approval of a rare disease drug ...
Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...
FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...
But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...
The Food and Drug Administration commissioner repeatedly said patients should rely on guidance from their doctors.
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
Marty Makary’s stewardship of the FDA will be key to the policy success of the Make America Healthy Again movement. Photo: drew angerer/Agence France-Presse/Getty Images ...